Gut Hormones in Health and Obesity: The Upcoming Role of Short Chain Fatty Acids

We are currently facing an obesity pandemic, with worldwide obesity rates having tripled since 1975. Obesity is one of the main risk factors for the development of non-communicable diseases, which are now the leading cause of death worldwide. This calls for urgent action towards understanding the underlying mechanisms behind the development of obesity as well as developing more effective treatments and interventions. Appetite is carefully regulated in humans via the interaction between the central nervous system and peripheral hormones. This involves a delicate balance in external stimuli, circulating satiating and appetite stimulating hormones, and correct functioning of neuronal signals. Any changes in this equilibrium can lead to an imbalance in energy intake versus expenditure, which often leads to overeating, and potentially weight gain resulting in overweight or obesity. Several lines of research have shown imbalances in gut hormones are found in those who are overweight or obese, which may be contributing to their condition. Therefore, this review examines the evidence for targeting gut hormones in the treatment of obesity by discussing how their dysregulation influences food intake, the potential possibility of altering the circulating levels of these hormones for treating obesity, as well as the role of short chain fatty acids and protein as novel treatments.     

Effects of Anthocyanin on Intestinal Health: A Systematic Review

Intestinal health relies on the association between the mucosal immune system, intestinal barrier and gut microbiota. Bioactive components that affect the gut microbiota composition, epithelial physical barrier and intestinal morphology were previously studied. The current systematic review evaluated evidence of anthocyanin effects and the ability to improve gut microbiota composition, their metabolites and parameters of the physical barrier; this was conducted in order to answer the question: “Does food source or extract of anthocyanin promote changes on intestinal parameters?”. The data analysis was conducted following the PRISMA guidelines with the search performed at PubMed, Cochrane and Scopus databases for experimental studies, and the risk of bias was assessed by the SYRCLE tool. Twenty-seven studies performed in animal models were included, and evaluated for limitations in heterogeneity, methodologies, absence of information regarding allocation process and investigators’ blinding. The data were analyzed, and the anthocyanin supplementation demonstrated positive effects on intestinal health. The main results identified were an increase of Bacteroidetes and a decrease of Firmicutes, an increase of short chain fatty acids production, a decrease of intestinal pH and intestinal permeability, an increase of the number of goblet cells and tight junction proteins and villi improvement in length or height. Thus, the anthocyanin supplementation has a potential effect to improve the intestinal health. PROSPERO (CRD42020204835).     

父母身高对7岁以下儿童身高影响效应的研究

目的 分析父母身高对7岁以下儿童身高的影响效应,为个体儿童生长评估提供参考依据。方法 以“2015年中国九市7岁以下儿童体格发育调查”中父母身高信息完整的161 297名儿童为分析对象,参照中国儿童身高标准计算儿童身高、父亲身高、母亲身高和父母身高中值的Z分值,采用Spearman方法分析儿童身高与父身高、母身高、父母身高中值的相关性,并按父母身高分组,比较各组儿童身高的差异。 结果 1)儿童身高与父身高、母身高和父母身高中值正相关(r=0.13~0.42,P<0.05),且与父母身高中值的相关系数最高;2)按父母身高中值分为矮身材、偏矮、中等偏下、中等偏上、较高、高身材6组,各组儿童平均身高依次递增,父母矮身材组儿童身高比父母高身材组低1.9~14.7 cm,年龄越大差值越大;3)父母身高偏矮组子女身高第3百分位(P₃)比中国儿童身高标准P₃低0.6~4.8 cm,而父母较高身材组P₃则比身高标准P₃高0.6~4.7 cm;4)父母矮身材、偏矮、中等偏下、中等偏上、较高和高身材组的儿童身高Z分值与父母身高中值Z分值差值依次为1.27±0.99、0.61±0.92、0.18±0.89、-0.19±0.90、-0.61±0.93、-1.17±0.92。结论 7岁以下儿童身高与父母身高正相关;矮身材父母的子女身高明显低于高身材父母子女;矮身材父母子女身高高于家庭遗传身高;个体儿童身高评估和解释时,不可忽视父母身高的影响作用。     

河南部分人群D_(16)S_(539)、D_7S_(820)、D_(13)S_(317)基因座遗传多态性分析

目的 :了解河南地区人群中D16S539、D7S82 0 、D13S317基因座的遗传多态性 ,获得群体遗传数据。方法 :对2 30份无血缘关系个体的抗凝血样提取DNA ,应用多位点复合PCR扩增技术结合聚丙烯酰胺凝胶电泳分型方法调查D16S539、D7S82 0 、D13S317基因座在河南地区群体中的基因型分布。结果 :D16S539基因座在河南地区人群中存在 9个等位基因 ,2 8种基因型 ;D7S82 0 基因座存在 9个等位基因 ,2 9种基因型 ;D13S317存在 8个等位基因 ,31种基因型。基因型频率分布符合Hardy Weinberg平衡。结论 :D16S539、D7S82 0 、D13S317基因座是进行人类群体遗传学和法医遗传学研究十分有用的遗传标记。     

中国北方汉族、维吾尔族、哈萨克族DYS19基因座的遗传多态性

目的;研究DYS19基因座在中国北方汉族、维吾尔族、哈萨克族群体中的遗传多态性及其法医学应用。方法：应用聚合酶链反应后变性聚丙烯酰胺凝胶电泳分离扩增产物结合银染显带的方法,对101例北方汉族、56例维吾尔族、30例哈萨克族无关男性个体的DYS19基因座进行检测。结果：DYS19基因座在3个群体中共检出5种等位基因,基因频率分布范围分别为0．069－0．594,0．071－0．500,0．100－0．667;个人识别机率分别为0．600,0．675,0．491。χ^2检验表明等位基因分布具有明显的人群差异。家系调查符合单体父系遗传方式。结论：DYS19基因座个人识别机率高,属较高鉴别能力的遗传标记系统,且具有明显的人群分布差异,在法医学及人类遗传学研究中具有重要的应用价值。     

Assessment of Psychological Factors in Short-Stay Total Hip Arthroplasty Protocol

BackgroundSeveral variables are known to correlate with the successful completion of short-stay total hip arthroplasty (THA) protocols. The role of psychological factors remains unclear. We investigated the interaction between patient-reported measures of psychological fitness and successful completion of a short-stay THA protocol.MethodsWe performed a prospective cohort study of patients undergoing elective anterior total hip arthroplasty enrolled in a short-stay protocol (success defined as LOS ≤1 midnight versus failed, LOS >1 midnight). Psychological fitness was measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) domains for self-efficacy, depression, anxiety, emotional support, and the ability to participate in social roles. PROMIS scores, patient demographics, and surgical factors were assessed for a relationship with failure to complete short-stay protocol.ResultsPatients that failed to complete the short-stay protocol had higher mean pre-operative PROMIS depression scores (50.8 vs 47.1, P = .025) and anxiety scores (53.6 vs 49.2, P = .008) and higher postoperative PROMIS depression (48.19 vs 43.49, P = .003) and anxiety scores (51.7 vs 47.1, P = .01). Demographic and surgical variables did not correlate with the successful completion of the short-stay protocol. That seventy-six percent of the patients did not adhere to the short-stay protocol was due to the inability to complete a physical therapy standardized safety assessment.ConclusionHigher levels of preoperative and postoperative anxiety and depression in otherwise psychologically healthy patients, is associated with an increased risk of failure to complete a short-stay protocol following THA. Targeted interventions are needed to facilitate rapid recovery in patients with psychological barriers to early mobilization.     

新型短节段内固定器治疗腰椎滑脱症的临床应用

目的：探讨新型短节段内固定器治疗腰椎滑脱症的临床应用价值。方法：对１８例腰椎滑脱的脊椎应用新型内固定器进行复位、固定,恢复脊椎的正常解剖结构,并自髂嵴后部取骨行横突间植骨融合。结果：术后随访１２￣２４个月,平均１８个月,滑脱复位率达９０％,４￣５月后达到骨性愈合,无螺钉松动,拨出,断裂及脊住骨滑脱现象。结论：新型短节段内固定器治疗腰椎滑脱症复位率高,固定螺钉松动,拨出,断裂及再滑脱等并发症少,疗效     

STR-PCR方法检测贵州小型香猪遗传变异性的研究

目的 准确分析贵州小型香猪种群遗传变异及近交程度。方法 采用１０对短串联重复序列（ＳＴＲ）引物,对贵州小型香猪个体进行ＰＣＲ检测。结果 在检测到的８８个有效等位基因型中,纯合基因型５０个,占５５．７％。个体平均杂合率为０．４０８１,位点平均杂合率为０．５５６２。结论 贵州小型香猪具有一定遗传稳定性,符合封闭群动物遗传学特征。     

Pediatric intestinal transplantation

Advancements in donor management, organ preservation and operative techniques, as well as immunosuppressive therapies, have provided children with intestinal failure and its complications a chance not only for enteral autonomy but also long-term survival through intestinal transplantation (ITx). First described in the 1960’s, experience has grown in managing these complex patients both pre- and post-transplant. The goals of this review are to provide a brief history of intestinal transplantation and intestinal rehabilitation in pediatric patients, followed by focused discussions of the indications for ITx, induction and maintenance immunosuppression therapies, common post-operative complications, and outcomes/quality of life post-transplant.     

Carrier detection and presymptomatic identification of Wilson disease in Chinese by non-isotopic linkage analysis with four short tandem repeat polymorphisms

Ｗｉｌｓｏｎｄｉｓｅａｓｅ（ＷＤ）ｉｓａｎａｕｔｏｓｏｍａｌｒｅｃｅｓｓｉｖｅｄｉｓｏｒｄｅｒｏｆｃｏｐｐｅｒｍｅｔａｂｏｌｉｓｍｗｉｔｈａｗｏｒｌｄｗｉｄｅｆｒｅｑｕｅｎｃｙｏｆｂｅｔｗｅｅｎ１／５０００ａｎｄ１／３００００ｉｎｌｉｖｅｂｉｒｔｈｓ...